Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is experiencing continued improvements in occupancy and rent coverage, contributing to a favorable outlook regarding its leverage profile. The expected recovery in the seniors housing managed portfolio positions the company to pursue growth opportunities, enhanced by favorable demand drivers in the healthcare real estate sector. Additionally, an increase in funds from operations (FFO) estimates, rising from $1.45 to $1.54 per share, reflects the company's capacity for higher investment volume and enhanced financial performance.

Bears say

The financial outlook for Sabra Health Care REIT is negatively impacted by the unpredictability of individual operator performance, particularly concerning their ability to fulfill rent obligations in the current inflationary environment. Additionally, the company's leverage position is not as favorable compared to several peers, which contributes to a higher risk profile. Furthermore, Sabra's current cost of equity, coupled with its trading position near the upper limit of its historical valuation range, suggests limited potential for immediate earnings growth through new acquisitions within the competitive healthcare REIT market.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.